The CDC’s Advisory Committee on Immunization Practices (ACIP) has been hard at work over the past year. Updated guidelines around certain vaccines and newly approved products have been on the committee’s agenda throughout 2023. These include respiratory syncytial virus (RSV) vaccines, updates regarding influenza vaccines, and potential vaccine candidates in the pipeline, among a few others.
During a presentation at the National Community Pharmacists Association (NCPA) 2023 Annual Convention and Expo, Jean-Venable R. Goode, PharmD, director of the PGY1 Community Based Residency Program at Virginia Commonwealth University, discussed in detail the new guidelines from ACIP.1
Flu Vaccines “You're probably already in the thick of influenza vaccines. So, this might be just a little bit late,” Goode told a room of pharmacists. “But we'll cover a couple things.”
The composition of flu vaccines have changed slightly this year to include a new strain. “They still have the same strain for H1N1, Victoria, and Wisconsin, but it’s a different strain number found in a different year,” Goode said.
Although recommendations around flu vaccines did not change, ACIP did make an update for people with egg allergies. People with the allergy no longer need to take any additional safety measures when it comes to receiving a flu vaccination. Unless a contraindication exists, anyone 6 months or older can receive any flu vaccine that’s appropriate for their age and health status.
Print Page
Email to a Friend